No abstract

MYCN amplification is tightly associated with the poor prognosis of pediatric neuroblastoma (NB). The regulation of NB cell death by MYCN represents an important aspect, as it directly contributes to tumor progression and therapeutic resistance. However, the relationship between MYCN and cell death remains elusive. Ferroptosis is a newly identified cell death mode featured by lipid peroxide accumulation that can be attenuated by GPX4, yet whether and how MYCN regulates ferroptosis are not fully understood. Here, we report that MYCN-amplified NB cells are sensitive to GPX4-targeting ferroptosis inducers. Mechanically, MYCN expression reprograms the cellular iron metabolism by upregulating the expression of TFRC, which encodes transferrin receptor 1 as a key iron transporter on the cell membrane. Further, the increased iron uptake promotes the accumulation of labile iron pool, leading to enhanced lipid peroxide production. Consistently, TFRC overexpression in NB cells also induces selective sensitivity to GPX4 inhibition and ferroptosis. Moreover, we found that MYCN fails to alter the general lipid metabolism and the amount of cystine imported by System Xc(−) for glutathione synthesis, both of which contribute to ferroptosis in alternative contexts. In conclusion, NB cells harboring MYCN amplification are prone to undergo ferroptosis conferred by TFRC upregulation, suggesting that GPX4-targeting ferroptosis inducers or TFRC agonists can be potential strategies in treating MYCN-amplified NB.

Developing a universal strategy to design piezochromic luminescent materials with desirable properties remains challenging. Here, we report that insertion of a non-emissive molecule into a donor (perylene) and acceptor (1,2,4,5-tetracyanobezene) binary cocrystal can realize fine manipulation of intermolecular interactions between perylene and 1,2,4,5-tetracyanobezene (TCNB) for desirable piezochromic luminescent properties. A continuous pressure-induced emission enhancement up to 3 GPa and a blue shift from 655 to 619 nm have been observed in perylene-TCNB cocrystals upon THF insertion, in contrast to the red-shifted and quenched emission observed when compressing perylene-TCNB cocrystals and other cocrystals reported earlier. By combining experiment with theory, it is further revealed that the inserted non-emissive THF forms blue-shifting hydrogen bonds with neighboring TCNB molecules and promote a conformation change of perylene molecules upon compression, causing the blue-shifted and enhanced emission. This strategy remains valid when inserting other molecules as non-emissive component into perylene-TCNB cocrystals for abnormal piezochromic luminescent behaviors.

HIGHLIGHTS • The TTC layer was efficiently deposited at the grain boundary of the perovskite, which passivated the grain surface and grain boundary, thereby decreasing the interfacial recombination of the perovskite solar cells. • The hydrophobic small molecule TTC on the perovskite films forms a water-resistant layer that protects the perovskite from water damage.

The PI-SERS signals of R6G molecules on a MoS2/Au substrate are enhanced at 2.39 GPa by a two-step charge transfer process.

The fabrication of silicon (Si) anode materials derived from high silica‐containing plants enables effective utilization of subsidiary agricultural products. However, the electrochemical performances of synthesized Si materials still require improvement and thus need further structural design and morphology modifications, which inevitably increase preparation time and economic cost. Here, the conversion of corn leaves into Si anode materials is reported via a simple aluminothermic reduction reaction without other modifications. The obtained Si material inherits the structural characteristics of the natural corn leaf template and has many inherent advantages, such as high porosity, amorphous/crystalline mixture structure, and high‐valence SiOx residuals, which significantly enhance the material's structural stability and electrode adhesive strength, resulting in superior electrochemical performances. Rate capability tests show that the material delivers a high capacity of 1200 mA h g−1 at 8 A g−1 current density. After 300 cycles at 0.5 A g−1, the material maintains a high specific capacity of 2100 mA h g−1, with nearly 100% capacity retention during long‐term cycling. This study provides an economical route for the industrial production of Si anode materials for Lithium‐Ion batteries.

No abstract

are co-inventors on invention disclosures related to targeting PTPN22 to treat cancers, developing novel compounds against PTPN22, and/or utilizing rs2476601 as a predictive biomarker for cancer immunotherapy. W.H. is a co-inventor of patents with potential for receiving royalties from Rodeo Therapeutics unrelated to the current study. M.Y. reports receiving research grants from Incyte, Bristol-Myers Squibb, and Exelixis, and is a consultant for AstraZeneca, Eisai, Exelixis, and Genentech. E.J.F. is a consultant for Champions Oncology. B.H.P. had ownership interest and was a paid member of the scientific advisory board of Loxo Oncology and was a paid consultant for Foundation Medicine, Inc, Lilly, Casdin Capital and Roche. He is currently a paid scientific advisory board member of Celcuity and a paid consultant for Jackson Laboratories and Pathovax. Under separate licensing agreements